Cyclo Therapeutics, Inc. Warrant
CYTHW
CYTHW was delisted on the 25th of March, 2025.
6 hedge funds and large institutions have $2.05M invested in Cyclo Therapeutics, Inc. Warrant in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$238K |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$109K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$72.8K |
| 4 |
AC
Armistice Capital
New York
|
+$61.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.28K |
Top Sellers
CYTHW Hedge Fund Activity: Q4 2020 in Review
6 of the 5,677 institutional investors tracked by Wall St. Rank reported a position in Cyclo Therapeutics, Inc. Warrant (CYTHW) for Q4 2020, worth a combined $2.05M.
Buyers outnumbered sellers: 6 funds opened new CYTHW positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $238K.
- 6 institutional investors held Cyclo Therapeutics, Inc. Warrant (CYTHW) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $2.05M of Cyclo Therapeutics, Inc. Warrant stock for Q4 2020.
- 6 funds opened new Cyclo Therapeutics, Inc. Warrant positions in Q4 2020 and 0 closed out, a net change of +6 holders.
- The largest Cyclo Therapeutics, Inc. Warrant buyer in Q4 2020 was Sabby Management, an estimated $238K added.
Based on aggregated 13F filings for Q4 2020.